Alina Markova

1.8k total citations
67 papers, 704 citations indexed

About

Alina Markova is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Alina Markova has authored 67 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Dermatology, 19 papers in Oncology and 18 papers in Epidemiology. Recurrent topics in Alina Markova's work include Chemotherapy-related skin toxicity (13 papers), Cutaneous lymphoproliferative disorders research (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Alina Markova is often cited by papers focused on Chemotherapy-related skin toxicity (13 papers), Cutaneous lymphoproliferative disorders research (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Alina Markova collaborates with scholars based in United States, Spain and Italy. Alina Markova's co-authors include Eliot N. Mostow, G. William Rebeck, Guojun Bu, Rosalind S.E. Carney, Kyung‐Jin Lee, Brian W. Howell, Ji-Yun Lee, Daniel T.S. Pak, J. Jack Lee and Hyang‐Sook Hoe and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Alina Markova

58 papers receiving 685 citations

Peers

Alina Markova

DERMA

ONCOL

PHYSI

EPIDE

Mary E. Ziegler United States

L. Richard France

Kazuko Fujita Japan

Claudia Specchia Italy

A. Wright United States

Laura Mercurio Italy

Giancarlo Discepoli Italy

Judy Qiang Canada

Pratap Gadangi United States

Mary E. Ziegler United States

Alina Markova

114 ×0.6

DERMA

225 ×1.3

90 ×0.7

ONCOL

91 ×0.8

PHYSI

44 ×0.5

EPIDE

Citations per year, relative to Alina Markova Alina Markova (= 1×) peers Mary E. Ziegler

Countries citing papers authored by Alina Markova

Since Specialization

Citations

This map shows the geographic impact of Alina Markova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alina Markova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alina Markova more than expected).

Fields of papers citing papers by Alina Markova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alina Markova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alina Markova. The network helps show where Alina Markova may publish in the future.

Co-authorship network of co-authors of Alina Markova

This figure shows the co-authorship network connecting the top 25 collaborators of Alina Markova. A scholar is included among the top collaborators of Alina Markova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alina Markova. Alina Markova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moy, Andrea P., Stephen W. Dusza, Alison J. Moskowitz, et al.. (2025). Dupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series. The Oncologist. 30(9). 2 indexed citations

Deutsch, Alana, et al.. (2025). Palliative oncodermatology: Management of malignancy-related cutaneous symptoms in the palliative care setting. Journal of the American Academy of Dermatology. 92(6). 1351–1359.

Markova, Alina, Azael Freites‐Martínez, Ian Tattersall, et al.. (2025). Low-Dose Oral Minoxidil during Chemotherapy: A Review of the Mechanism and Current Evidence. Skin Appendage Disorders. 12(1). 29–37.

Dusza, Stephen W., et al.. (2024). Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System. Transplantation and Cellular Therapy. 30(10). 1035.e1–1035.e7. 2 indexed citations

Markova, Alina, et al.. (2024). Clinical presentations of skin of color in oncodermatology. Journal of the American Academy of Dermatology. 92(2). 357–364.

Babakoohi, Shahab, et al.. (2023). Dermatologic complications in transplantation and cellular therapy for acute leukemia. Best Practice & Research Clinical Haematology. 36(2). 101464–101464. 2 indexed citations

Moy, Andrea P., Stephen W. Dusza, Yelena Y. Janjigian, et al.. (2023). Management of immune-related cutaneous adverse events with dupilumab. Journal for ImmunoTherapy of Cancer. 11(6). e007324–e007324. 25 indexed citations

Markova, Alina, et al.. (2023). Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events. Pharmaceuticals. 16(11). 1610–1610. 5 indexed citations

Dusza, Stephen W., Elizabeth Quigley, Alina Markova, et al.. (2023). Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients. Breast Cancer Research and Treatment. 203(2). 271–280. 2 indexed citations

10.

Shear, Neil H., et al.. (2023). A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy. Biomedicines. 11(2). 323–323. 5 indexed citations

11.

Markova, Alina, Esperanza B. Papadopoulos, Stephen W. Dusza, et al.. (2023). Topical Ruxolitinib for Chronic Cutaneous GvHD: Promising Results of a Phase 2 Clinical Trial. Blood. 142(Supplement 1). 777–777. 1 indexed citations

12.

Barrios, Dulce M., Melissa Pulitzer, Andrea P. Moy, et al.. (2023). Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience. Acta Haematologica. 147(4). 457–464. 2 indexed citations

13.

Nocco, Sarah E., Arpita Bose, Marina Chilov, et al.. (2022). Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 174. 103696–103696. 7 indexed citations

14.

Mori, Shoko, et al.. (2020). Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer. Journal of the American Academy of Dermatology. 84(2). 273–282. 13 indexed citations

15.

Hedayat, A., Travis J. Hollmann, Michael A. Marchetti, et al.. (2019). Gram‐negative cutaneous infections with unique filamentous forms. Journal of Cutaneous Pathology. 46(6). 459–462. 1 indexed citations

16.

Markova, Alina, et al.. (2019). Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014. Journal of the American Academy of Dermatology. 81(3). 740–748. 16 indexed citations

17.

Markova, Alina, et al.. (2017). Benign and malignant hybrid adnexal tumors in a patient with epidermodysplasia verruciformis. Journal of Cutaneous Pathology. 44(11). 969–973. 1 indexed citations

18.

Phillips, Gregory S., Azael Freites‐Martínez, Meier Hsu, et al.. (2017). Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients. Journal of the American Academy of Dermatology. 78(6). 1102–1109. 22 indexed citations

19.

Markova, Alina & Martin A. Weinstock. (2010). Trends in Cutaneous Lymphoma Epidemiology. Clinical Lymphoma Myeloma & Leukemia. 10. S63–S66. 9 indexed citations

20.

Hoe, Hyang‐Sook, Kyung‐Jin Lee, Rosalind S.E. Carney, et al.. (2009). Interaction of Reelin with Amyloid Precursor Protein Promotes Neurite Outgrowth. Journal of Neuroscience. 29(23). 7459–7473. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact